REDHILL BIOPHARMA LTD. Financial Assets At Fair Value Through Profit Or Loss
REDHILL BIOPHARMA LTD. (RDHL) had Financial Assets At Fair Value Through Profit Or Loss of $481.00 thousand as of 2020-12-31, per its 20-F filed 2022-03-17.
Discontinued › Notes
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss · last filed 2022-03-17
- 2020-12-31: Financial Assets At Fair Value Through Profit Or Loss $481.00K.
- 2020-06-30: Financial Assets At Fair Value Through Profit Or Loss $4.51M.
- 2019-12-31: Financial Assets At Fair Value Through Profit Or Loss $8.50M.
- 2019-06-30: Financial Assets At Fair Value Through Profit Or Loss $16.47M.
| Period end | Financial Assets At Fair Value Through Profit Or Loss |
|---|---|
| 2020-12-31 | $481.00K 20-F · filed 2022-03-17 |
| 2020-06-30 | $4.51M 6-K · filed 2020-08-13 |
| 2019-12-31 | $8.50M 20-F · filed 2021-03-18 |
| 2019-06-30 | $16.47M 6-K · filed 2019-07-23 |
| 2018-12-31 | $15.91M 20-F · filed 2020-03-04 |
| 2018-06-30 | $14.11M 6-K · filed 2018-08-30 |
| 2017-12-31 | $16.59M 20-F · filed 2019-02-26 |
| 2016-12-31 | $12.31M 20-F · filed 2018-02-22 |